Covalon Enters into Automatic Share Purchase Plan
MISSISSAUGA, ON, June 30, 2022 /PRNewswire/ – Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF) (the “Company” or “Covalon”), an advanced medical technologies company, today announced
Save on Your Membership
Be One of the firsts to learn about every ticker's critical news. Subsribe today and save on your membership.
View Membership Options>
>
MISSISSAUGA, ON, June 30, 2022 /PRNewswire/ – Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF) (the “Company” or “Covalon”), an advanced medical technologies company, today announced
MISSISSAUGA, ON, May 30, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its
MISSISSAUGA, ON, May 26, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTC: CVALF), an advanced medical technologies company, will release
MISSISSAUGA, ON, May 19, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced
MISSISSAUGA, ON / ACCESSWIRE / April 28, 2022 / Covalon Technologies Ltd. (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88
MISSISSAUGA, ON, April 26, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced
MISSISSAUGA, ON, March 29, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today is
MISSISSAUGA, ON, March 10, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, announced today the